These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4088990)

  • 1. [Case of severe ophthalmopathy in euthyroidism].
    Zalevskaia AG; Blagosklonnaia IaV
    Probl Endokrinol (Mosk); 1985; 31(6):40-1. PubMed ID: 4088990
    [No Abstract]   [Full Text] [Related]  

  • 2. [The relationship of endocrine ophthalmopathy to the thyroid status and to the indices of an autoimmune lesion of the thyroid].
    Biriukova MP; Kandror VI; Kriukova IV; Konnova EV; Kozlov GI; Efuni SS; Polianskaia IS
    Probl Endokrinol (Mosk); 1990; 36(5):10-4. PubMed ID: 2080135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of prednisolone disposition in patients with Graves' disease taking methimazole.
    Legler UF
    J Clin Endocrinol Metab; 1988 Jan; 66(1):221-3. PubMed ID: 3335606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab: a novel treatment for sight-threatening thyroid associated ophthalmopathy.
    Durrani OM; Reuser TQ; Murray PI
    Orbit; 2005 Jun; 24(2):117-9. PubMed ID: 16191800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid stimulation-blocking antibody and Graves' ophthalmopathy.
    Kubota S; Fukata S; Amino N; Miyauchi A
    Thyroid; 2006 Jul; 16(7):708. PubMed ID: 16889500
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy.
    Hiromatsu Y; Kojima K; Ishisaka N; Tanaka K; Sato M; Nonaka K; Nishimura H; Nishida H
    Thyroid; 1992; 2(4):299-305. PubMed ID: 1493371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The correlations between thyroid pathology and ophthalmopathy].
    Kandror VI; Biriukova MP; Kriukova IV; Mkrtumova NA; Konnova EV
    Probl Endokrinol (Mosk); 1990; 36(4):78-83. PubMed ID: 2122440
    [No Abstract]   [Full Text] [Related]  

  • 8. [Endocrine ophthalmopathy and autoimmune thyroid diseases].
    Karlsson A; Dahlberg PA; Enoksson P; Boström L; Sääf M; Sjöberg HE; Tallstedt L
    Lakartidningen; 1985 Jul; 82(28-29):2504-7. PubMed ID: 4021654
    [No Abstract]   [Full Text] [Related]  

  • 9. [Endocrine ophthalmopathy].
    Pickardt CR; Boergen KP; Heinze HG
    Internist (Berl); 1974 Oct; 15(10):497-505. PubMed ID: 4611949
    [No Abstract]   [Full Text] [Related]  

  • 10. Some immunological correlations between thyroid pathology and ophthalmopathy.
    Kandror V; Birjukova M; Kryukova I; Mkrtumova N; Konnova E
    Exp Clin Endocrinol; 1991 May; 97(2-3):212-6. PubMed ID: 1915637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between clinical activity score and thyroid autoantibodies in patients with thyroid ophthalmopathy.
    Hsu SY; Chang CH; Su MY; Wang HZ; Tsai RK
    Kaohsiung J Med Sci; 2000 Oct; 16(10):533-8. PubMed ID: 11272800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ocular and orbital circulations in dysthyroid ophthalmopathy.
    Cant JS; Wilson TM
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):416-29. PubMed ID: 4549701
    [No Abstract]   [Full Text] [Related]  

  • 13. [Function of the hypophyseo-thyroid system in patients with post-thyrotoxic encephalo-ophthalmopathy].
    Oleĭnik VA; Epshteĭn EV; Luchitskiĭ EV
    Vrach Delo; 1988 Sep; (9):72-5. PubMed ID: 3213004
    [No Abstract]   [Full Text] [Related]  

  • 14. Graves ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids.
    Nakahara H; Noguchi S; Murakami N; Morita M; Tamaru M; Ohnishi T; Hoshi H; Jinnouchi S; Nagamachi S; Futami S
    Radiology; 1995 Sep; 196(3):857-62. PubMed ID: 7644656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necrotizing scleritis after ocular surgery.
    Lyne AJ; Lloyd-Jones D
    Trans Ophthalmol Soc U K (1962); 1979 Apr; 99(1):146-9. PubMed ID: 297368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of endocrine ophthalmopathy].
    Raith L
    Z Allgemeinmed; 1973 Dec; 49(35):1727-30. PubMed ID: 4131142
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of thyroid uptake by iodine absorbed with eye-drop therapy.
    Ceccarelli C; Grasso L; Martino E; Nardi M
    J Nucl Med; 1982 Apr; 23(4):364. PubMed ID: 7069502
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy.
    Salvi M; Bernard N; Miller A; Zhang ZG; Gardini E; Wall JR
    Thyroid; 1991; 1(3):207-13. PubMed ID: 1824337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined cyclosporin-A and methylprednisolone treatment of Graves' ophthalmopathy.
    Leövey A; Bakó G; Szabó J; Kálmán K; Fórizs E
    Acta Med Hung; 1992-1993; 49(3-4):179-85. PubMed ID: 1345455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of endocrine ophthalmopathy].
    Schneider C
    Fortschr Med; 1974 Aug; 92(22):950-2. PubMed ID: 4411341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.